Critical analysis challenges the scientific basis for the cannabis "entourage effect" | Research

The takeaway

A critical review of the primary literature behind the cannabis "entourage effect" found that claims of synergistic benefits from whole-plant cannabis are poorly defined, largely unsubstantiated, and exploited by a poorly regulated industry.

Cannabis consumers, industry professionals, pharmacologists, regulators

The entourage effect was first proposed as a hypothesis in 1998; rigorous evidence remains lacking

What the researchers found

The entourage effect concept, first proposed as a hypothesis in 1998, has been promoted as an established therapeutic principle despite lacking robust evidence. The review found that commonly cited phytochemicals have their own adverse effects, claims invoke ill-defined pharmacological activities, and the scientific literature has been overinterpreted to support marketing claims.

Why it matters

The entourage effect is widely used to market whole-plant cannabis products as superior to purified cannabinoids. Understanding whether this claim has scientific merit affects consumer choices and product regulation.

The numbers in context

The entourage effect was first coined in 1998. The review examines multiple primary sources commonly cited as evidence and finds them insufficient to support the broad claims made.

How the study worked

Critical analysis of the primary literature commonly cited as supporting the entourage effect, supplemented with PubMed and Google Scholar searches. Examines the original hypothesis, contributing phytochemicals, and their adverse effects.

What this study cannot tell us

This is one perspective; some researchers and clinicians do report clinical differences between whole-plant and isolated cannabinoid preparations. The absence of proof is not proof of absence.

How to read the evidence

Thorough critical analysis of primary literature, though representing one analytical perspective on a debated topic.

When this study was published

Published in 2020.

The bigger picture

The gap between the entourage effect as a reasonable hypothesis worth investigating and its current status as a marketing tool highlights broader concerns about evidence standards in the cannabis industry.

Questions still open

Could well-designed comparative trials settle the entourage effect debate? Are there specific compound combinations that do produce synergistic effects?

Common questions

Is the entourage effect real?

The concept that cannabis compounds work better together than in isolation is a reasonable hypothesis, but this review found that the primary evidence cited in its support is weaker than commonly presented. Rigorous comparative clinical trials are needed to determine if specific combinations produce genuine synergistic effects.

Why does this matter for consumers?

Many cannabis products are marketed as "full spectrum" or "whole plant" with claims that they are superior due to the entourage effect. This review suggests consumers should be skeptical of these claims until they are backed by more rigorous evidence.

Read the original research

The 'entourage effect' or 'hodge-podge hashish': the questionable rebranding, marketing, and expectations of cannabis polypharmacy.

Expert review of clinical pharmacology, 13(8), 835-845

View on PubMed ↗Publisher’s paper ↗

Citation

Cogan, Peter S. (2020). The 'entourage effect' or 'hodge-podge hashish': the questionable rebranding, marketing, and expectations of cannabis polypharmacy.. Expert review of clinical pharmacology, 13(8), 835-845. https://doi.org/10.1080/17512433.2020.1721281